B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment
出版年份 2015 全文链接
标题
B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment
作者
关键词
B cells, Fatigue, Patients, Mental health and psychiatry, Phase II clinical investigation, Autoimmune diseases, Myalgia, Cancer detection and diagnosis
出版物
PLoS One
Volume 10, Issue 7, Pages e0129898
出版商
Public Library of Science (PLoS)
发表日期
2015-07-02
DOI
10.1371/journal.pone.0129898
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Distinct plasma immune signatures in ME/CFS are present early in the course of illness
- (2015) M. Hornig et al. Science Advances
- Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients
- (2014) Ana Luisa Calich et al. JOURNAL OF AUTOIMMUNITY
- Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 study
- (2014) P. S. Sorensen et al. NEUROLOGY
- Autoimmune Basis for Postural Tachycardia Syndrome
- (2014) Hongliang Li et al. Journal of the American Heart Association
- Anti-CD20 monoclonal antibodies: Beyond B-cells
- (2013) Irit Avivi et al. BLOOD REVIEWS
- The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment
- (2013) G. Cambridge et al. JOURNAL OF AUTOIMMUNITY
- Rituximab in Relapsing and Progressive Forms of Multiple Sclerosis: A Systematic Review
- (2013) Tamara Castillo-Trivino et al. PLoS One
- Epitopes of Microbial and Human Heat Shock Protein 60 and Their Recognition in Myalgic Encephalomyelitis
- (2013) Amal Elfaitouri et al. PLoS One
- Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type
- (2013) Catherine Thieblemont et al. SEMINARS IN CANCER BIOLOGY
- Rituximab for the treatment of rheumatoid arthritis: an update
- (2013) Chi Chiu Mok Drug Design Development and Therapy
- Complex regional pain syndrome, prototype of a novel kind of autoimmune disease
- (2012) Andreas Goebel et al. AUTOIMMUNITY REVIEWS
- Chronic fatigue syndrome and subsequent risk of cancer among elderly US adults
- (2012) Cindy M. Chang et al. CANCER
- Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls
- (2012) A. S. Bradley et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Induction of long-term B-cell depletion in refractory rheumatoid arthritis patients preferentially affects autoreactive more than protective humoral immunity
- (2012) YK Onno Teng et al. ARTHRITIS RESEARCH & THERAPY
- Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis
- (2011) David B. Clifford ARCHIVES OF NEUROLOGY
- Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis
- (2011) Jérémie Sellam et al. ARTHRITIS AND RHEUMATISM
- Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care
- (2011) Luis C Nacul et al. BMC Medicine
- Evidence for a heritable predisposition to Chronic Fatigue Syndrome
- (2011) Frederick Albright et al. BMC Neurology
- The functional status and well being of people with myalgic encephalomyelitis/chronic fatigue syndrome and their carers
- (2011) Luis C Nacul et al. BMC PUBLIC HEALTH
- Neutropenia after rituximab treatment
- (2011) Ofir Wolach et al. CURRENT OPINION IN HEMATOLOGY
- Outcome measurement in functional somatic syndromes: SF-36 summary scores and some scales were not valid
- (2011) Andreas Schröder et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Autoimmunity against the β2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome
- (2011) Danielle Kohr et al. PAIN
- Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study
- (2011) Øystein Fluge et al. PLoS One
- Effectiveness of rituximab treatment in primary Sjögren's syndrome: A randomized, double-blind, placebo-controlled trial
- (2010) J. M. Meijer et al. ARTHRITIS AND RHEUMATISM
- Ofatumumab, a human anti-CD20 monoclonal antibody, for treatment of rheumatoid arthritis with an inadequate response to one or more disease-modifying antirheumatic drugs: Results of a randomized, double-blind, placebo-controlled, phase I/II study
- (2010) Mikkel Østergaard et al. ARTHRITIS AND RHEUMATISM
- Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arthritis
- (2010) H. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series
- (2009) Øystein Fluge et al. BMC Neurology
- The late adverse events of rituximab therapy – rare but there!
- (2009) Ron Ram et al. LEUKEMIA & LYMPHOMA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now